Precision Urology Canada offers a revolutionary approach to prostate cancer treatment with IRE (Irreversible Electroporation) therapy, skillfully administered using the cutting-edge NanoKnife system.
We pride ourselves on our patient-focused approach, emphasizing the highest possible standards using NanoKnife/IRE (Irreversible Electroporation) therapy.
-
Excellent cancer control
-
Low risk of urinary issues
-
Low risk of sexual dysfunction
-
Out-patient procedure
-
Short general anesthetic
WHY NANOKNIFE?
At PRECISION UROLOGY CANADA, we are the first centre in Canada to provide leading edge focal therapy using NanoKnife, a revolutionary targeted tratment for prostate cancer.
We pride ourselves on our patient-focused approach, emphasizing the highest possible standards using NanoKnife/IRE (Irreversible Electroporation) therapy.
Precision Urology Canada offers a revolutionary approach to prostate cancer treatment with IRE (Irreversible Electroporation) therapy, skillfully administered using the cutting-edge NanoKnife system.
We pride ourselves on our patient-focused approach, emphasizing the highest possible standards using NanoKnife/IRE (Irreversible Electroporation) therapy.
-
Excellent cancer control
-
Low risk of urinary issues
-
Low risk of sexual dysfunction
-
Out-patient procedure
-
Short general anesthetic
WHY NANOKNIFE?
Precision Urology Canada offers a revolutionary approach to prostate cancer treatment with IRE (Irreversible Electroporation) therapy, skillfully administered using the cutting-edge NanoKnife system.
We pride ourselves on our patient-focused approach, emphasizing the highest possible standards using NanoKnife/IRE (Irreversible Electroporation) therapy.
WHY NANOKNIFE?
-
Excellent cancer control
-
Low risk of urinary issues
-
Low risk of sexual dysfunction
-
Out-patient procedure
-
Short general anesthetic
About
NanoKnife is a focal therapy that uses IRE which stands for “Irreversible Electroporation”, a cutting-edge technique used in treating certain cancers, including prostate cancer. IRE utilizes the power of electrical pulses to target and destroy cancerous cells.
This precise targeting is made possible through advanced real time imaging and specialized equipment, ensuring the highest level of safety and effectiveness. This treatment is minimally invasive and performed under general anesthesia on an outpatient basis.
IRE generates very little heat, which is particularly beneficial for tumors in delicate areas like the prostate, where preserving healthy tissue, such as the bladder, urethra, urinary sphincter, rectum, and erectile nerves, is crucial. This results in minimal side effects and complications.
In the news
In the news
Pivotal Studies
Pivotal Studies
IRE specifically targets cancer cells while preserving healthy tissue, improving treatment outcomes and long-term success in controlling prostate cancer.
Precise and Effective
IRE is performed on an outpatient basis, allowing you to return home the same day of the treatment, ensuring minimal disruption to your daily routines.
Outpatient Procedure
IRE treatment maintains prostate functionality and minimizes side effects like urinary incontinence and sexual dysfunction. Unlike radiation it does not cause secondary cancers in adjacent organs. In the unlikely event of a treatment failure, radiation and surgery remain options for salvage treatment.
Preserves Quality of Life
No incisions are made, leading to reduced pain, a shorter recovery period, and lower risk of complications compared to radical prostate surgery.
Minimally Invasive
Pivotal Studies
NanoKnife Advantages
Preserves Quality of Life
IRE treatment maintains prostate functionality and minimizes side effects like urinary incontinence and sexual dysfunction. Unlike radiation it does not cause secondary cancers in adjacent organs. In the unlikely event of a treatment failure, radiation and surgery remain options for salvage treatment.
NanoKnife Advantages
Minimally Invasive
No incisions are made, leading to reduced pain, a shorter recovery period, and lower risk of complications compared to radical prostate surgery.
Precise and Effective
IRE specifically targets cancer cells while preserving healthy tissue, improving treatment outcomes and long-term success in controlling prostate cancer.
How it Works
-
NanoKnife is not covered by government insurance plans (OHIP). It is a fee based private medical service paid for by the patient.
-
The procedure is performed in a state-of-the-art, fully equipped, inspected and certified private surgical facility.
-
You will go home on the day of your procedure.
-
The procedure causes minimal discomfort.
Outpatient Procedure
IRE is performed on an outpatient basis, allowing you to return home the same day of the treatment, ensuring minimal disruption to your daily routines.
Pivotal Studies
In the news
Pivotal Studies
In the news
Pivotal Studies
In the news
Our Team
Dr. Jerome A. Green
MD FRCSC
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
Dr. John L. Preiner
MD, FRCSC
Dr. Preiner graduated from medical school at the University of Toronto in 1993. He was a resident in anesthesia from 1993 to 1995 and passed his fellowship exams in Urologic Surgery with the Royal College of Surgeons of Canada in 2000. He completed a fellowship in Urodynamics and Reconstructive Urology at Sunnybrook Hospital in Toronto in 2001. He is currently the Division Chief in Urology at Southlake Regional Health Centre in Newmarket, Ontario, the Chairperson for Genito-urinary Multi-disciplinary Cancer Rounds at the Stronach Regional Cancer Centre, and Lecturer at the University of Toronto Medical School. He has a general adult and paediatric urologic practice including the diagnosis and treatment of prostate, bladder, kidney and testis cancer, with a special interest in minimally invasive surgery. He as been actively involved with the delivery of IRE or the nano knife procedure to patients with prostate cancer since it was first performed in Canada in November of 2022.
Dr. Luke Fazio
MD, FRCSC
Dr. Fazio completed medical school at McGill University. He did his residency in urology at Western University and completed a fellowship in endourology and minimally invasive surgery through the University of Toronto at St. Michael’s Hospital. He was an associate staff at Queen’s University prior to joining the Division of Urology at Humber River Hospital. His practice focuses on endourology as well as minimally-invasive and robotic surgery. He is the current Division Head for urology at Humber River and co-chair of the robotic surgery program. He also serves as director of urology for TCBH Surgical Centre.
Dr. Jerome
A. Green
MD FRCSC
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
Dr. John L. Preiner
MD, FRCSC
Dr. Preiner graduated from medical school at the University of Toronto in 1993. He was a resident in anesthesia from 1993 to 1995 and passed his fellowship exams in Urologic Surgery with the Royal College of Surgeons of Canada in 2000. He completed a fellowship in Urodynamics and Reconstructive Urology at Sunnybrook Hospital in Toronto in 2001. He is currently the Division Chief in Urology at Southlake Regional Health Centre in Newmarket, Ontario, the Chairperson for Genito-urinary Multi-disciplinary Cancer Rounds at the Stronach Regional Cancer Centre, and Lecturer at the University of Toronto Medical School. He has a general adult and paediatric urologic practice including the diagnosis and treatment of prostate, bladder, kidney and testis cancer, with a special interest in minimally invasive surgery. He as been actively involved with the delivery of IRE or the nano knife procedure to patients with prostate cancer since it was first performed in Canada in November of 2022.
Dr. Luke Fazio
MD, FRCSC
Dr. Fazio completed medical school at McGill University. He did his residency in urology at Western University and completed a fellowship in endourology and minimally invasive surgery through the University of Toronto at St. Michael’s Hospital. He was an associate staff at Queen’s University prior to joining the Division of Urology at Humber River Hospital. His practice focuses on endourology as well as minimally-invasive and robotic surgery. He is the current Division Head for urology at Humber River and co-chair of the robotic surgery program. He also serves as director of urology for TCBH Surgical Centre.
Dr. Jerome A. Green
MD FRCSC
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
Dr. John L. Preiner
MD, FRCSC
Dr. Preiner graduated from medical school at the University of Toronto in 1993. He was a resident in anesthesia from 1993 to 1995 and passed his fellowship exams in Urologic Surgery with the Royal College of Surgeons of Canada in 2000. He completed a fellowship in Urodynamics and Reconstructive Urology at Sunnybrook Hospital in Toronto in 2001. He is currently the Division Chief in Urology at Southlake Regional Health Centre in Newmarket, Ontario, the Chairperson for Genito-urinary Multi-disciplinary Cancer Rounds at the Stronach Regional Cancer Centre, and Lecturer at the University of Toronto Medical School. He has a general adult and paediatric urologic practice including the diagnosis and treatment of prostate, bladder, kidney and testis cancer, with a special interest in minimally invasive surgery. He as been actively involved with the delivery of IRE or the nano knife procedure to patients with prostate cancer since it was first performed in Canada in November of 2022.
Dr. Luke Fazio
MD, FRCSC
Dr. Fazio completed medical school at McGill University. He did his residency in urology at Western University and completed a fellowship in endourology and minimally invasive surgery through the University of Toronto at St. Michael’s Hospital. He was an associate staff at Queen’s University prior to joining the Division of Urology at Humber River Hospital. His practice focuses on endourology as well as minimally-invasive and robotic surgery. He is the current Division Head for urology at Humber River and co-chair of the robotic surgery program. He also serves as director of urology for TCBH Surgical Centre.
We are a team of experts, Canadian trained, Royal College Certified Urologists with over 60 years of combined experience treating prostate cancer. We are at the forefront of medical advancements, specializing in IRE prostate cancer treatment using the “state of the art” NanoKnife system which offers the best care possible.
Comprehensive Patient Centred care:
Facing prostate cancer can be overwhelming, but you don't have to go through it alone. We understand the importance of maintaining sexual vitality, urinary continence, and minimizing life disruptions. We prioritize your well-being and tailor your treatment plan to your unique needs. From the initial consultation to post-treatment follow-ups, we provide comprehensive care and support throughout your entire journey.
We are a team of experts, Canadian trained, Royal College Certified Urologists with over 60 years of combined experience treating prostate cancer. We are at the forefront of medical advancements, specializing in IRE prostate cancer treatment using the “state of the art” NanoKnife system which offers the best care possible.
Comprehensive Patient Centred Care:
Facing prostate cancer can be overwhelming, but you don't have to go through it alone. We understand the importance of maintaining sexual vitality, urinary continence, and minimizing life disruptions. We prioritize your well-being and tailor your treatment plan to your unique needs. From the initial consultation to post-treatment follow-ups, we provide comprehensive care and support throughout your entire journey.
Schedule a Consult
We are a team of experts, Canadian trained, Royal College Certified Urologists with over 60 years of combined experience treating prostate cancer. We are at the forefront of medical advancements, specializing in IRE prostate cancer treatment using the “state of the art” NanoKnife system which offers the best care possible.
Comprehensive Patient Centred Care:
Facing prostate cancer can be overwhelming, but you don't have to go through it alone. We understand the importance of maintaining sexual vitality, urinary continence, and minimizing life disruptions. We prioritize your well-being and tailor your treatment plan to your unique needs. From the initial consultation to post-treatment follow-ups, we provide comprehensive care and support throughout your entire journey.
Dr. Jerome
A. Green
MD FRCSC
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
With over 19 years of urology practice in Newmarket, Dr. Green is a distinguished staff Urologist at Southlake Regional Health Centre. He obtained his Medical Degree from Memorial University of Newfoundland in 1999 and completed his urology residency at The University of Ottawa in 2004. Dr. Green pursued advanced training with a fellowship in Andrology and Reconstruction at Sunnybrook Health Sciences Centre, University of Toronto. His expertise encompasses the management of benign and malignant urologic diseases, specializing prominently in prostate cancer.
Our Team
Dr. John L. Preiner
MD, FRCSC
Dr. Preiner graduated from medical school at the University of Toronto in 1993. He was a resident in anesthesia from 1993 to 1995 and passed his fellowship exams in Urologic Surgery with the Royal College of Surgeons of Canada in 2000. He completed a fellowship in Urodynamics and Reconstructive Urology at Sunnybrook Hospital in Toronto in 2001. He is currently the Division Chief in Urology at Southlake Regional Health Centre in Newmarket, Ontario, the Chairperson for Genito-urinary Multi-disciplinary Cancer Rounds at the Stronach Regional Cancer Centre, and Lecturer at the University of Toronto Medical School. He has a general adult and paediatric urologic practice including the diagnosis and treatment of prostate, bladder, kidney and testis cancer, with a special interest in minimally invasive surgery. He as been actively involved with the delivery of IRE or the nano knife procedure to patients with prostate cancer since it was first performed in Canada in November of 2022.
Dr. Luke Fazio
MD, FRCSC
Dr. Fazio completed medical school at McGill University. He did his residency in urology at Western University and completed a fellowship in endourology and minimally invasive surgery through the University of Toronto at St. Michael’s Hospital. He was an associate staff at Queen’s University prior to joining the Division of Urology at Humber River Hospital. His practice focuses on endourology as well as minimally-invasive and robotic surgery. He is the current Division Head for urology at Humber River and co-chair of the robotic surgery program. He also serves as director of urology for TCBH Surgical Centre.
We are a team of experts, Canadian trained, Royal College Certified Urologists with over 60 years of combined experience treating prostate cancer. We are at the forefront of medical advancements, specializing in IRE prostate cancer treatment using the “state of the art” NanoKnife system which offers the best care possible.
Comprehensive Patient Centred Care:
Facing prostate cancer can be overwhelming, but you don't have to go through it alone. We understand the importance of maintaining sexual vitality, urinary continence, and minimizing life disruptions. We prioritize your well-being and tailor your treatment plan to your unique needs. From the initial consultation to post-treatment follow-ups, we provide comprehensive care and support throughout your entire journey.
In the news
In the news
Preserves Quality of Life:
IRE treatment maintains prostate functionality and minimizes side effects like urinary incontinence and sexual dysfunction. Unlike radiation it does not cause secondary cancers in adjacent organs. In the unlikely event of a treatment failure, radiation and surgery remain options for salvage treatment.
Minimally Invasive:
No incisions are made, leading to reduced pain, a shorter recovery period, and lower risk of complications compared to radical prostate surgery.
Precise and Effective:
IRE specifically targets cancer cells while preserving healthy tissue, improving treatment outcomes and long-term success in controlling prostate cancer.
Outpatient Procedure:
IRE is performed on an outpatient basis, allowing you to return home the same day of the treatment, ensuring minimal disruption to your daily routines.